Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnevist-enhanced MRA in Renal Artery Stenosis
NCT00310557Phase 3Completed
- Sponsor
- Bayer
- Start
- Dec 2003
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of gadopentetate dimeglumine in renal artery stenosis (RAS), sponsored by Bayer. Started Dec 2003; status: completed.
02
Drugs
gadopentetate dimeglumine
03
Conditions
renal artery stenosis (RAS)
Beyond the preview
Go deeper on NCT00310557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00310557.